CD40LG and Insulin resistance: A recent study demonstrated that B-1a cells attenuate insulin resistance and glucose metabolism through anti-inflammatory cytokine interleukin- (IL-) 10 and polyclonal IgM-dependent mechanisms, while B-2 cells exacerbate metabolic disease [19].